# AZD8075 Single Ascending Dose Study

> **NCT00787072** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 72 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD8075
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00787072
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 72 (ESTIMATED)
- **Why stopped:** After reports of turbidity in urine in 4 of 8 volunteers in the 4th cohort, the study was halted temporarily.
- **Last updated:** 2010-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787072, "AZD8075 Single Ascending Dose Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00787072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*